This article was originally published in The Gray Sheet
Maker of automated blood processing systems says it will acquire the remaining 80% of Transfusion Technologies Corp. not already owned. The cash deal was announced Sept. 5. Haemonetics will gain Tranfusion Technologies' orthopedic perioperative autotransfusion system OrthoPat, which incorporates Dynamic Disc centrifuge technology, as well as access to the Chairside Separator, an automated whole blood collection device in late-stage development. The Dynamic Disk centrifuge system "has tremendous synergy with Haemonetics' core product line and a very promising marketing potential," the firm says. Last November, Haemonetics bought about 20% of TTC for $15 mil
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.